BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Byrne TJ, Rakela J. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy. World J Transplant 2016; 6(2): 306-313 [PMID: 27358775 DOI: 10.5500/wjt.v6.i2.306]
URL: https://www.wjgnet.com/1948-5182/full/v6/i2/306.htm
Number Citing Articles
Sophia Schmitz, Georg Lurje, Florian Ulmer, Anne Andert, Philipp Bruners, Maximilian Schulze-Hagen, Ulf Neumann, Wenzel Schoening. Loco-regional hepatocellular carcinoma treatment services as a bridge to liver transplantationHepatobiliary & Pancreatic Diseases International 2019; 18(3): 228 doi: 10.1016/j.hbpd.2019.01.004
Ana-Maria Bucalau, Illario Tancredi, Gontran Verset. In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?Cancers 2021; 13(20): 5129 doi: 10.3390/cancers13205129
Experimental and Clinical Transplantation 2017; 15(Suppl 2) doi: 10.6002/ect.TOND16.L2
Allison N. Martin, Luke R. Wilkins, Deepanjana Das, Lily E. Johnston, Todd W. Bauer, Reid B. Adams, Victor M. Zaydfudim. Efficacy of Radiofrequency Ablation versus Transarterial Chemoembolization for Patients with Solitary Hepatocellular Carcinoma ≤3 cmThe American Surgeon 2019; 85(2): 150 doi: 10.1177/000313481908500220
Anum Aslam, Amita Kamath, Bradley Spieler, Mark Maschiocchi, Carl F. Sabottke, Victoria Chernyak, Sara C. Lewis. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agentsAbdominal Radiology 2021; 46(8): 3565 doi: 10.1007/s00261-021-03076-x
Zhenru Zhu, Chuanhui Cao, Dongyan Zhang, Zhihong Zhang, Li Liu, Dehua Wu, Jingyuan Sun. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolismCell Death & Disease 2022; 13(2) doi: 10.1038/s41419-022-04596-0
Sandeep A. Ponniah, Andreas G. Zori, Roniel Cabrera. Liver Cancer2021; : 127 doi: 10.36255/exonpublications.livercancer.2021.ch7
William C. Chapman, Kevin M. Korenblat, Kathryn J. Fowler, Nael Saad, Adeel S. Khan, Vijay Subramanian, Maria B. Majella Doyle, Leigh Anne Dageforde, Benjamin Tan, Patrick Grierson, Yiing Lin, Min Xu, Elizabeth M. Brunt. Hepatocellular carcinoma: Where are we in 2018?Current Problems in Surgery 2018; 55(11): 450 doi: 10.1067/j.cpsurg.2018.10.002
Alberto Unzueta, Roniel Cabrera. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and CholangiocarcinomaClinics in Liver Disease 2017; 21(2): 231 doi: 10.1016/j.cld.2016.12.002
Won Chang, Jeong Min Lee, Jeong Hee Yoon, Dong Ho Lee, Sang Min Lee, Kyoung Bun Lee, Bo Ram Kim, Tae-Hyung Kim, Seunghyun Lee, Joon Koo Han, Gianfranco D. Alpini. No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine liversPLOS ONE 2017; 12(4): e0176350 doi: 10.1371/journal.pone.0176350
Hla-Hla Thein, Wanrudee Isaranuwatchai, Yao Qiao, Kenny Wong, Gonzalo Sapisochin, Kelvin K. W. Chan, Eric M. Yoshida, Craig C. Earle. Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian settingCancer Medicine 2017; 6(9): 2017 doi: 10.1002/cam4.1119